Tom White

Tom White is the co-founder and current President & CEO of TriAct Therapeutics, a late clinical stage cancer therapeutics company, since February 2008. In addition to this role, Tom serves as the Chair of the Board of Directors for Reading Partners, a non-profit organization dedicated to providing literacy intervention services to at-risk youth in grades K-5, and holds a position on the Board of Directors for Pomega Inc., specializing in wound care. Previously, Tom served on the Board of Directors for EciOsis Therapeutics, Inc. and Genomic Systems, Inc., and was the co-founder and President & CEO of BiPar Sciences, Inc., another clinical stage cancer therapeutics company. Tom's earlier experience includes a senior executive role as SVP of Commercial Strategy and Chief Marketing Officer at Shaman Pharmaceuticals, and Director of Marketing at Pete's Brewing Company. Tom White earned a Master of Science in Journalism & Advertising from Northwestern University and a Bachelor of Journalism from the University of Missouri-Columbia.